MARFIN RANDEL S 4
4 · LUMINEX CORP · Filed Mar 21, 2006
Insider Transaction Report
Form 4
LUMINEX CORPLMNX
MARFIN RANDEL S
VP, Luminex Bioscience Group
Transactions
- Exercise/Conversion
Common Stock
2006-03-17$6.52/sh+25,000$163,000→ 49,355 total - Sale
Common Stock
2006-03-17$15.00/sh−25,000$375,000→ 24,355 total - Exercise/Conversion
Employee Stock Option (Right to buy)
2006-03-17−25,000→ 0 totalExercise: $6.52From: 2005-05-23Exp: 2012-05-23→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The sales was effected pursuant to instructions set forth in a Rule 10b5-1 trading plan previously established by the reporting person.